FR2059541B1 - - Google Patents

Info

Publication number
FR2059541B1
FR2059541B1 FR7026720A FR7026720A FR2059541B1 FR 2059541 B1 FR2059541 B1 FR 2059541B1 FR 7026720 A FR7026720 A FR 7026720A FR 7026720 A FR7026720 A FR 7026720A FR 2059541 B1 FR2059541 B1 FR 2059541B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7026720A
Other languages
French (fr)
Other versions
FR2059541A1 (https=
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orica Ltd
Original Assignee
ICI Australia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICI Australia Ltd filed Critical ICI Australia Ltd
Publication of FR2059541A1 publication Critical patent/FR2059541A1/fr
Application granted granted Critical
Publication of FR2059541B1 publication Critical patent/FR2059541B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7026720A 1969-07-21 1970-07-20 Expired FR2059541B1 (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU5831169 1969-07-21

Publications (2)

Publication Number Publication Date
FR2059541A1 FR2059541A1 (https=) 1971-06-04
FR2059541B1 true FR2059541B1 (https=) 1974-10-11

Family

ID=3743604

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7026720A Expired FR2059541B1 (https=) 1969-07-21 1970-07-20

Country Status (9)

Country Link
US (1) US3670086A (https=)
BE (1) BE753710A (https=)
CA (1) CA964193A (https=)
DE (1) DE2036114C3 (https=)
FR (1) FR2059541B1 (https=)
GB (1) GB1287673A (https=)
IE (1) IE34373B1 (https=)
NL (1) NL165653C (https=)
ZA (1) ZA704419B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096271A (en) * 1977-08-03 1978-06-20 American Cyanamid Company Slow release injectable formulations of tetramisole and derivatives in benzyl benzoate
BRPI0413558A (pt) 2003-08-12 2006-10-17 3M Innovative Properties Co compostos contendo imidazo substituìdo por hidroxilamina
AU2004268625B2 (en) 2003-08-27 2011-03-31 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
AU2004270201A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
AR046046A1 (es) 2003-10-03 2005-11-23 3M Innovative Properties Co Imidazoquinolinas alcoxi sustituidas. composiciones farmaceuticas.
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
EP1685129A4 (en) 2003-11-14 2008-10-22 3M Innovative Properties Co OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
CA2545825A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
CA2547020C (en) 2003-11-25 2014-03-25 3M Innovative Properties Company 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
EP1699788A2 (en) 2003-12-30 2006-09-13 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
WO2005094531A2 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US20070259881A1 (en) * 2004-06-18 2007-11-08 Dellaria Joseph F Jr Substituted Imidazo Ring Systems and Methods
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
JP2008526752A (ja) * 2004-12-30 2008-07-24 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調節剤化合物の多経路投与
EP1831221B1 (en) 2004-12-30 2012-08-08 3M Innovative Properties Company Substituted chiral fused 1,2 imidazo 4,5-c ring compounds
JP5543068B2 (ja) 2004-12-30 2014-07-09 スリーエム イノベイティブ プロパティズ カンパニー キラル縮合[1,2]イミダゾ[4,5−c]環状化合物
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
AU2006213746A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
AU2006232375A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
EP1869043A2 (en) 2005-04-01 2007-12-26 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
CN104906036A (zh) * 2015-06-12 2015-09-16 重庆市畜牧科学院 阿魏酸左旋咪唑注射液的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131034C (https=) * 1964-05-11
AU421744B2 (en) * 1967-08-24 1972-02-24 I. C. I. Australia Limited Chemical process

Also Published As

Publication number Publication date
FR2059541A1 (https=) 1971-06-04
DE2036114C3 (de) 1979-09-13
NL165653B (nl) 1980-12-15
DE2036114B2 (de) 1979-01-18
CA964193A (en) 1975-03-11
DE2036114A1 (de) 1971-02-04
BE753710A (fr) 1970-12-31
NL7010558A (https=) 1971-01-25
ZA704419B (en) 1971-04-28
NL165653C (nl) 1981-05-15
IE34373L (en) 1971-01-21
IE34373B1 (en) 1975-04-16
GB1287673A (en) 1972-09-06
US3670086A (en) 1972-06-13

Similar Documents

Publication Publication Date Title
FR2059541B1 (https=)
AU465413B2 (https=)
AU450150B2 (https=)
AU442375B2 (https=)
CS151042B2 (https=)
AU2355770A (https=)
AU470301B1 (https=)
AU5113869A (https=)
AU442535B2 (https=)
AU442285B2 (https=)
AU442538B2 (https=)
AT308690B (https=)
AU442554B2 (https=)
AU442463B2 (https=)
AU470661B1 (https=)
AU442357B2 (https=)
AU442322B2 (https=)
AU438128B2 (https=)
AU410358B2 (https=)
AR203167Q (https=)
CS152743B1 (https=)
AU4949169A (https=)
AU4540468A (https=)
AU5109569A (https=)
AU5077469A (https=)

Legal Events

Date Code Title Description
CD Change of name or company name